SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

PDRN Salmon Sperm Peptide Serum: Polynucleotides as Bioactive Skin Regenerators

PDRN (Polydeoxyribonucleotide) refers to a class of high molecular weight DNA fragments primarily derived from salmon sperm (Oncorhynchus mykiss) that are used as bioactive ingredients in skincare. By activating adenosine A2A receptors and providing DNA building blocks, they stimulate cellular repair mechanisms, promote collagen synthesis, and possess pronounced anti-inflammatory properties. In serum formulations, polynucleotides are considered one of the most research-intensive bioactive ingredients in contemporary dermatology.

Term and Origin

The term PDRN stands for Polydeoxyribonucleotide — a polymer of deoxyribonucleotide monomers, i.e., the basic chemical building blocks of DNA. The abbreviation has become established in clinical and cosmetic contexts as a shorthand for a specific fraction of enzymatically hydrolyzed DNA obtained from the sperm or gonadal cells of Atlantic salmon (Salmo salar) or rainbow trout (Oncorhynchus mykiss). The use of fish DNA in medicine dates back to the 1990s, when Italian research groups first systematically investigated the tissue-regenerative effect of PDRN injections on wounds and ischemic tissues.

The term "salmon sperm peptide" is a simplifying, sometimes misleading, designation in the cosmetic market: Chemically, it is not peptides (short amino acid chains) but polynucleotides — i.e., chains of nucleotide units. Nevertheless, the terminology "peptide" has become prevalent in the product communication of many brands, possibly due to its conceptual proximity to other bioactive ingredients. Within the regulatory framework of EU Cosmetics Regulation 1223/2009, such DNA derivatives are evaluated as cosmetic ingredients as long as no therapeutic claims are made.

In South Korea, where PDRN has been used for years as an aesthetic-medical injectable product (keywords: "Salmon DNA Injection" or "PDRN Booster"), topical application in serum form has established itself as a distinct product category since the mid-2010s. The K-Beauty environment has played a decisive role in its global recognition — a phenomenon closely related to the popularization of other marine active ingredients from K-Beauty research.

Characteristics & Mechanism of Action

PDRN acts via two biochemically distinct pathways. First, it activates adenosine A2A receptors on fibroblasts, keratinocytes, and immune cells. These G-protein-coupled receptors are classic mediators of anti-inflammatory signaling cascades: their stimulation inhibits the release of pro-inflammatory cytokines such as TNF-α and IL-6 and simultaneously promotes the production of growth factors, particularly VEGF (Vascular Endothelial Growth Factor) and TGF-β1. This explains the observed improvement in microvascularization and accelerated wound healing after PDRN application in clinical studies. Second, PDRN functions as a "salvage pathway activator": the DNA fragments provide purine bases and pyrimidines that can be directly used by damaged cells for DNA repair and resynthesis, without having to resort to the energy-intensive de novo synthesis pathway.

Regarding collagen synthesis, in vitro and clinical studies show that PDRN-treated fibroblasts produce significantly higher amounts of type I collagen. This is particularly relevant in the context of inflammaging — the chronic silent inflammatory process considered one of the main drivers of intrinsic skin aging. The anti-inflammatory effect of PDRN can interrupt this cycle at a molecular level. Additionally, an antioxidative side activity is discussed, which can act synergistically with classic antioxidants.

For topical application, molecular size is crucial: high molecular weight PDRN (>1,000 kDa) hardly penetrates the intact skin barrier, which is why advanced formulations rely on technologies such as nanoencapsulation, liposome delivery, or hydrogel carriers. Low molecular weight fractions, known as oligonucleotides (PN, Polynucleotides High Purity), show improved epidermal penetration in studies. The quality and purity of the starting fraction — measured by the content of undesirable proteins and the degree of fragmentation — is therefore a central quality characteristic that makes the formulation more important than simply the list of ingredients.

Skincare Approach

PDRN serums are typically applied after cleansing and before heavier moisturizing formulations — following the "light to heavy" principle, which is fundamental to any effective facial skincare approach. Since PDRN itself has no strong occlusive effect, it is well-suited as a functional layer in a multi-step routine. A sensible sequence would be: gentle cleanser, optional balancing toner, PDRN serum, followed by moisturizer or occlusion.

In cosmetic formulations, concentrations of 0.1–2% PDRN/PN are considered typical; higher concentrations are the subject of clinical-aesthetic applications. Combination synergies exist particularly with ceramides (barrier stabilization), bakuchiol (complementary fibroblast stimulation without irritant potential), and ectoin (protection against hypertonic stress reactions). PDRN is particularly interesting for sensitive skin, as it does not cause a primary irritation reaction, unlike retinol or aggressive acids. Initial positive observations have also been made for skin prone to dermatitis or inflammatory dysregulation.

In the NATURFACTOR® range, the Porcelain Skin Serum combines bioactive regeneration concepts with barrier-intelligent formulation. In addition, the Blue Crystal Drops with their antioxidant active ingredient complex address the oxidative stress pathway that often occurs in parallel with cellular repair deficits. For a comprehensive overview of the serum category as a whole, the article on scientific criteria for anti-aging serums 2026 is recommended.

Realistic Expectations

PDRN is not an immediate active ingredient. The cellular repair cascade initiated by adenosine receptor activation and DNA building block availability operates on the timeline of biological processes: initial improvements in skin texture, moisture retention, and skin calmness are typically visible after 4–8 weeks of consistent use. Studies on subjects with photodamaged skin show measurable reductions in fine lines and improved skin density after 12 weeks. Significant effects on deeper hyperpigmentation or pronounced volume deficits, as addressed by clinical injection therapy, are not to be expected from a topical serum alone.

Individual variation is considerable: genetic polymorphisms in adenosine receptors, skin barrier status, and the quality of the formulation significantly influence the result. Skin with a compromised skin barrier or chronically dehydrated skin often shows measurable improvements earlier, as the cellular stress status increases the need for DNA repair substrates. It makes sense to view PDRN as part of a rhythm-oriented, targeted skincare routine, not as an isolated quick fix.

Frequently Asked Questions

Is PDRN from salmon sperm suitable for vegans or those with fish allergies?

PDRN is of animal origin (fish) and therefore not vegan. Caution is advised for individuals with fish allergies: Although proteins are largely removed during purification, highly sensitized skin could theoretically react to residual proteins. While relevant clinical studies show no systematic allergic reactions to pharmaceutically pure PDRN, individual hypersensitivity testing is still recommended. Plant-based alternatives such as plant-derived polynucleotides from yeasts (e.g., RNA derivatives) are being researched but are less clinically established.

How do PDRN and PN (Polynucleotides) differ?

Both terms describe DNA fragments from marine sources, but they differ in purity and fragment size. PDRN, in the stricter sense, refers to the crude mixture of various oligonucleotide chains obtained by enzymatic hydrolysis, while PN (Polynucleotides High Purity, often marketed under the brand name PNHP) refers to a more highly purified, protein-poor fraction. In clinical practice, the terms are often used synonymously; for topical formulations, the PN fraction is preferred due to better penetration depth and lower irritation potential.

Can PDRN be combined with active acids like AHA or BHA?

Basically, yes, but the order and timing are relevant. AHA or BHA exfoliants should not be applied immediately together with PDRN, as the low pH of the acids can potentially destabilize polynucleotide structures. It is recommended to apply them separately in time — acid exfoliants in the evening, PDRN serum in the morning or on alternating evenings. In the chronobiological skincare context, such a time-structured routine offers additional efficiency advantages.

Conclusion

PDRN salmon sperm serums represent a new generation of bioactive ingredients at the interface between dermatology and topical skincare. Their dual mechanism of action — adenosine receptor activation and DNA building block availability — makes them a scientifically sound approach for skin texture improvement, regeneration, and anti-inflammatory stabilization. In daily skincare, realistic expectation horizons (4–12 weeks) and a quality-conscious choice of formulation are crucial. As a building block in a holistic, skin quality-oriented approach — especially in combination with barrier care, antioxidant protection, and chronobiologically informed application — PDRN is one of the most convincing developments in modern active ingredient cosmetics.

1. Guizzardi S. et al. (2003). Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. Cardiovascular & Hematological Agents in Medicinal Chemistry, 1(1), 9–16.
2. Veronesi F. et al. (2015). In vivo and in vitro investigation of polydeoxyribonucleotide in cartilage repair and as a tissue stimulator. Journal of Orthopaedic Research, 33(8), 1218–1226.
3. Lee H. J. & Kim D. W. (2020). Skin Rejuvenation Using Polydeoxyribonucleotide (PDRN) with a Radiofrequency Procedure: A Randomized, Evaluator-Blinded Study. Journal of Cosmetic and Laser Therapy, 22(1), 1–7.
4. Cavallini M. et al. (2021). The use of polynucleotides (PDRN and PN-HPT™) in aesthetic medicine and surgery. Journal of Biological Regulators and Homeostatic Agents, 35(2 Suppl 1), 35–42.
5. Bitto A. et al. (2008). Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A2A receptor. British Journal of Pharmacology, 153(5), 1114–1123.